Clinical and Preclinical Models in Drug Abuse: Training and Development

药物滥用的临床和临床前模型:培训和开发

基本信息

  • 批准号:
    8286888
  • 负责人:
  • 金额:
    $ 12.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The purpose of this Senior Scientist Research and Mentorship Award (K05) application is to allow me (Richard W. Foltin, Ph.D.) protected time so that I may continue to mentor junior faculty. In this way I will share with the junior faculty much of what I learned from my mentors and in turn have my research benefit from what I learn from the junior faculty. Specifically, I will share my experience in conducting well-controlled, laboratory- based studies in areas that are difficult to model (relapse, putative medication effects on drug self- administration, estimating reinforcing values of behavior) with junior colleagues who are hoping to bring similar powerful methodologies to bear on their areas of expertise. Goal 1. Research: Aim 1. Maintain active research programs using laboratory models of drug abuse in non-human primates and drug-experienced human volunteers. My active support has always played a role in providing both research opportunities and salary support for junior faculty. I have 2 active R01s and 2 pending R01 submissions that will be used to support my research and provide training opportunities. Aim 2. Expand my research interests by incorporating the expertise of junior faculty I am mentoring in neuropsychology, magnetic resonance imaging, eating disorders and geriatric psychiatry. Goal 2. Training: Aim 1. Continue to be a valuable resource to the more senior faculty in our research group whom I have mentored since they completed their postdoctoral fellowships. Aim 2. Help the individuals whom I mentored on their K awards who are in their 4th and 5th years and now transitioning to independent status. Aim 3. Provide guidance to the individuals whom I mentor that are in the first several years of their K awards. Aim 4. Keep a discernible profile in departmental affairs so that I can be an advocate for drug abuse research and the needs of junior faculty. I have sufficient mentoring responsibilities to account for my mentoring effort over the next 5 years. Generally the junior faculty I mentor will first conduct projects that will be funded as part of one of my R01s, and then apply for divisional funds for pilot studies where possible prior to submitting a K application. This model has worked well in the past and will be used to develop new K awards for junior faculty.
描述(由申请人提供):此高级科学家研究和指导奖(K05)申请的目的是让我(理查德·W·福尔廷博士)有受保护的时间,以便我可以继续指导初级教师。通过这种方式,我将与初级教师分享我从导师那里学到的大部分知识,反过来,我的研究也会从我从初级教师那里学到的东西中受益。具体来说,我将与初级同事分享我在难以建模的领域(复发、假定的药物对药物自我管理的影响、估计行为的强化价值)进行良好控制的、基于实验室的研究的经验,他们希望将类似的强大方法应用于他们的专业领域。 目标 1. 研究:目的 1. 利用非人类灵长类动物和有药物经验的人类志愿者的药物滥用实验室模型维持积极的研究计划。我的积极支持一直在为初级教师提供研究机会和薪资支持方面发挥着作用。我有 2 个有效的 R01 和 2 个待提交的 R01,它们将用于支持我的研究并提供培训机会。目标 2. 通过整合我所指导的初级教师在神经心理学、磁共振成像、饮食失调和老年精神病学方面的专业知识来扩大我的研究兴趣。 目标 2. 培训:目标 1. 继续成为我们研究组中更高级的教师的宝贵资源,自从他们完成博士后奖学金以来我一直在指导他们。目标 2. 帮助我指导的获得 K 奖的个人,他们正处于第四年和第五年,现在正在过渡到独立身份。目标 3. 为我指导的 K 奖头几年的个人提供指导。目标 4. 在部门事务中保持明显的形象,以便我能够成为药物滥用研究和初级教师需求的倡导者。 我有足够的指导责任来承担我未来 5 年的指导工作。一般来说,我指导的初级教师将首先开展作为我的 R01 的一部分资助的项目,然后在提交 K 申请之前尽可能申请部门资金进行试点研究。这种模式过去运作良好,将用于为初级教师制定新的 K 奖。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard W Foltin其他文献

Richard W Foltin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard W Foltin', 18)}}的其他基金

Automated Speech Analysis: A Marker of Drug Intoxication & Treatment Outcome
自动语音分析:药物中毒的标志
  • 批准号:
    9232130
  • 财政年份:
    2016
  • 资助金额:
    $ 12.82万
  • 项目类别:
Impulsivity In Cocaine Abusers: Relationship to Drug Taking and Treatment Outcome
可卡因滥用者的冲动:与吸毒和治疗结果的关系
  • 批准号:
    8694439
  • 财政年份:
    2014
  • 资助金额:
    $ 12.82万
  • 项目类别:
Impulsivity In Cocaine Abusers: Relationship to Drug Taking and Treatment Outcome
可卡因滥用者的冲动:与吸毒和治疗结果的关系
  • 批准号:
    9040137
  • 财政年份:
    2014
  • 资助金额:
    $ 12.82万
  • 项目类别:
Impulsivity In Cocaine Abusers: Relationship to Drug Taking and Treatment Outcome
可卡因滥用者的冲动:与吸毒和治疗结果的关系
  • 批准号:
    9252429
  • 财政年份:
    2014
  • 资助金额:
    $ 12.82万
  • 项目类别:
Hypocretin Antagonists as a Novel Approach to Medication Development
下丘脑分泌素拮抗剂作为药物开发的新方法
  • 批准号:
    8233458
  • 财政年份:
    2011
  • 资助金额:
    $ 12.82万
  • 项目类别:
Clinical and Preclinical Models in Drug Abuse: Training and Development
药物滥用的临床和临床前模型:培训和开发
  • 批准号:
    8685228
  • 财政年份:
    2011
  • 资助金额:
    $ 12.82万
  • 项目类别:
Hypocretin Antagonists as a Novel Approach to Medication Development
下丘脑分泌素拮抗剂作为药物开发的新方法
  • 批准号:
    8106887
  • 财政年份:
    2011
  • 资助金额:
    $ 12.82万
  • 项目类别:
Clinical and Preclinical Models in Drug Abuse: Training and Development
药物滥用的临床和临床前模型:培训和开发
  • 批准号:
    8488420
  • 财政年份:
    2011
  • 资助金额:
    $ 12.82万
  • 项目类别:
Hypocretin Antagonists as a Novel Approach to Medication Development
下丘脑分泌素拮抗剂作为药物开发的新方法
  • 批准号:
    8445339
  • 财政年份:
    2011
  • 资助金额:
    $ 12.82万
  • 项目类别:
Clinical and Preclinical Models in Drug Abuse: Training and Development
药物滥用的临床和临床前模型:培训和开发
  • 批准号:
    8164971
  • 财政年份:
    2011
  • 资助金额:
    $ 12.82万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 12.82万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 12.82万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 12.82万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 12.82万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 12.82万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 12.82万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 12.82万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 12.82万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 12.82万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 12.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了